These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4678968)

  • 1. Time-dependent changes in brain 3 H-norepinephrine disappearance caused by L-DOPA administration.
    Hyyppä MT; Wurtman RJ
    Life Sci I; 1972 Aug; 11(15):713-21. PubMed ID: 4678968
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 3. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone.
    Reigle TG; Avni J; Platz PA; Schildkraut JJ; Plotnikoff NP
    Psychopharmacologia; 1974 Jun; 37(1):1-6. PubMed ID: 4213267
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of brain L-dopa concentration with -chymotrypsin.
    Seneca H; Henderson E
    J Am Geriatr Soc; 1973 Jun; 21(6):256-8. PubMed ID: 4710643
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of DOPA on catecholamine metabolism in spinal pain syndrome].
    Matlina ESh; Pukhova GS; Grafova VN; Kassil' GN; Kryshanovskii GN
    Vopr Med Khim; 1973; 19(2):173-6. PubMed ID: 4707507
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effects of 6-hydroxyDOPA and its interaction with DOPA on brain amine levels.
    Clarke DE; Smookler HH; Hadinata J; Chi C; Barry H
    Life Sci I; 1972 Feb; 11(3):97-102. PubMed ID: 4653197
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of L-dopa on the concentrations of tryptophan, tyrosine and serotonin in rat brain.
    Karobath M; Díaz JL; Huttunen MO
    Eur J Pharmacol; 1971 May; 14(4):393-6. PubMed ID: 5157767
    [No Abstract]   [Full Text] [Related]  

  • 11. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 12. L-DOPA: effect on ethanol narcosis and brain biogenic amines in mice.
    Blum K; Calhoun W; Merritt J; Wallace JE
    Nature; 1973 Apr; 242(5397):407-9. PubMed ID: 4735636
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
    Yamori Y; De Jong W; Yamabe H; Lovenberg W; Sjoerdsma A
    J Pharm Pharmacol; 1972 Sep; 24(9):690-5. PubMed ID: 4404071
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 16. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
    Extein I; Roth RH; Bowers MB
    Biol Psychiatry; 1974 Oct; 9(2):161-70. PubMed ID: 4429746
    [No Abstract]   [Full Text] [Related]  

  • 18. Norepinephrine pools in rat brain: differences in turnover rates and pathways of metabolism.
    Schildkraut JJ; Draskoczy PR; Lo PS
    Science; 1971 May; 172(3983):587-8. PubMed ID: 5555080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
    [No Abstract]   [Full Text] [Related]  

  • 20. Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs.
    Aghajanian GK; Bloom FE
    J Pharmacol Exp Ther; 1967 Jun; 156(3):407-16. PubMed ID: 6027453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.